Home Authors Posts by Luisa Beltran

Luisa Beltran

I've been a business reporter for a while. I've covered Wall Street, venture capital and now private equity. I'm always looking for a scoop or something to talk about. I'm the eternal optimist and am still waiting for the Chicago Cubs to win the World Series. Yes, I believe.
The results of our David Sokol poll surprised me. Yesterday, I asked what might happen to the former heir apparent at Berkshire Hathaway. Sokol, in case you've forgotten, bought Lubrizol shares and then pushed Warren Buffett to buy the company. Sokol, who was chairman of several Berkshire units, resigned after his Lubrizol trades became known. Berkshire shareholders are expected to convene in Omaha tomorrow for the annual meeting. Buffett is sure to be grilled about his poor handling of the scandal. Right now, we don't care about that. We want to know what will happen to Sokol.
Meritech Capital Partners said Wednesday that it has closed its latest fund at $425 million. Meritech Capital Partners IV will target four sectors: Internet and Digital Media, Communications and Wireless, Enterprise IT and Medical Devices. Meritech's last fund, MCP III, raised $400 million. Palo Alto, Calif.-based Meritech is a late-stage VC firm.
Avatar Ventures said Monday that it has closed a $500,000 fully subscribed private placement. The deal includes an up to $3 million financing commitment from a non-U.S. corporation. Avatar Ventures develops aftermarket electronic accessories and software for consumer products.
Greycroft Partners said Monday that it has added three senior executives. Paul Bricault, a former EVP of the William Morris Agency, has joined as a venture partner in Los Angeles. Kirill Sheynkman, the CEO of three enterprise software start-ups on the West Coast including Elastra, is joining Greycroft as a venture partner in New York. And, Alan Gould, who founded IAG, is an executive in residence at Greycroft's New York office. Also, Marissa Campise was promoted to principal of Greycroft.
Our weekly poll results were delayed because of the holidays. Last week, we asked very weighty, life-changing questions: Do you think the white iPhone 4 will ever see the light of day? And, if you had to choose, would you buy the white version 4.0 over Apple's next installment? The results were surprising. Especially since there have been so many rumors about the white iPhone 4. Apple introduced the iPhone 4 last summer and the white version was supposed to go up for sale last July. But manufacturing problems caused Apple to put these plans on hold. We've been waiting for the white version ever since.
AngioScore said Wednesday that it has received $12 million in PE financing led by Saints Capital. Existing institutional investors include Psilos Group Managers, Telegraph Hill Partners, QuestMark Partners, Pelion Venture Partners, California Technology Ventures and Innomed Ventures. Freemont, Calif.-based AngioScore is an endovascular company. Scott Halsted, a Saints Capital MD, was named to AngioScore's board.
Will McLean, VP and CIO of Northwestern University, and Andreas Ritter, past Private Equity Investment Manager for DUMAC, have joined Square 1 Ventures as independent members of the firm's investment committee.
NovoCure, which is backed by WFD Ventures, has been granted approval by the FDA to markets its treatment for glioblastoma multiforme.
Haddington Ventures has invested in Eureka Resources, a Williamsport, Pa.-based wastewater treatment company. Financial terms were not announced. Haddington Ventures makes control investments in energy companies.
Susquehanna Growth Equity has bought MediMedia Information Technologies. Financial terms were not announced. Yardley, Pa.-based MediMedia provides managed care information for the healthcare industry. PRESS RELEASE Susquehanna Growth Equity, LLC (SGE) today announced that it has acquired MediMedia Information Technologies, LLC (MMIT), a provider of managed care information for the healthcare industry. MMIT engages in […]
vcj
vcj

Copyright PEI Media

Not for publication, email or dissemination